Growth Metrics

Femasys (FEMY) Other Non Operating Income (2020 - 2025)

Femasys posted quarterly Other Non Operating Income of -$260000.0 for Q2 2025, down 131.65% on a QoQ basis from $821515.0 in Q2 2021.

Femasys (FEMY) has 3 years of Other Non Operating Income data on file, last reported at -$260000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Other Non Operating Income changed N/A year-over-year to -$260000.0; the trailing twelve-month figure through Jun 2025 stood at -$260000.0 (changed N/A YoY), and the FY2025 full-year result was -$482562.0, changed N/A from the prior year.
  • Other Non Operating Income for Q2 2025 stood at -$260000.0, down from $821515.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $821515.0 in Q2 2021 and bottomed at -$260000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Femasys 22.30 Mn 16.91 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -260,000.00
Jun 30, 2021 821,515.00
Dec 31, 2020 10,000.00